ICON Web & News
Search Using OECD Database
Return to Previous Page
Addition or Correction
Biodistribution and In Vivo Anticancer Effects of Taxol Loaded Magnetic Nanospheres
Link to Journal Abstract
Taxol (anticancer drug) loaded magnetic nanospheres were prepared and tested in vitro and in vivo in mice. Poly(D,L-lactide-co-glycolide) (PLGA) as polymer matrix for the encapsulation of the drug and magnetic (Fe3O4) particles was used. Pluronic F68 served as a stabilising agent of the polymeric nanospheres. The cytotoxicity of taxol loaded magnetic NPs suspensions towards B16 melanoma cells was investigated. Growth inhibitions of around 90% were reached in three days of exposition. Biodistribution of taxol administered in Cremophor-based injection formula as well as taxol loaded nanosphere compositions was determined in the plasma, selected organs and target tissue. The drug-loaded magnetically labeled nanospheres caused a reduction in tumor weight. A better result was achieved using the composition with higher magnetite/drug weight ratio than in the sample with the smaller ratio which is due to fact that the samples with higher magnetite content were trapped more effectively in target site (tumor) by the external field.
For this study, Taxol (anticancer drug) loaded magnetic (Fe3O4) nanospheres were prepared and tested in vitro and in vivo in mice. The cytotoxicity of taxol loaded magnetic NPs suspensions towards B16 melanoma cells was investigated.
Peer Reviewed Journal Article
Exposure Or Hazard Target
Method Of Study
Risk Exposure Group
IEEE Transactions on Magnetics, 49(1): 353-358 (January 2013)
IEEE Transactions on Magnetics
Kubovcikova M, Koneracka M, Zavisova V, Muckova M, Timko M, Schmidtova L, Bartos P, Kopcansky P
Last updated on February 11, 2013
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Good Nano Guide
Nano EHS Research Needs
Current Practices Survey